{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T04:23:31Z","timestamp":1743913411107},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s00292-014-1911-5","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T07:29:26Z","timestamp":1404372566000},"page":"355-360","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Spezialisierte histopathologische Zweitbegutachtung fortgeschrittener Ovarialkarzinome"],"prefix":"10.1007","volume":"35","author":[{"given":"S.","family":"Kommoss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Pfisterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"du Bois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kommoss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,5]]},"reference":[{"key":"1911_CR1","unstructured":"Howlader N, Noone A, Krapcho M et al (Hrsg) (2012) SEER Cancer Statistics Review, 1975\u20132009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012"},{"key":"1911_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.2002.6711","volume":"86","author":"Trimble","year":"2002","unstructured":"Trimble CL, Kosary C, Trimble EL (2002) Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecol Oncol 86(1):34\u201337","journal-title":"Gynecol Oncol"},{"key":"1911_CR3","doi-asserted-by":"crossref","unstructured":"du Bois A et al (2013) Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynakologische Onkologie (AGO) Study Group. Eur J Cancer","DOI":"10.1016\/j.ejca.2013.01.035"},{"key":"1911_CR4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9378(91)90628-5","volume":"164","author":"Tyler","year":"1991","unstructured":"Tyler CW Jr et al (1991) The diagnosis of ovarian cancer by pathologists: how often do diagnoses by contributing pathologists agree with a panel of gynecologic pathologists? Am J Obstet Gynecol 164(1 Pt 1):65\u201370","journal-title":"Am J Obstet Gynecol"},{"key":"1911_CR5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1054\/bjoc.1999.0994","volume":"82","author":"Sengupta","year":"2000","unstructured":"Sengupta PS et al (2000) Requirement for expert histopathological assessment of ovarian cancer and borderline tumors. Br J Cancer 82(4):760\u2013762","journal-title":"Br J Cancer"},{"key":"1911_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000478-200402000-00001","volume":"28","author":"Leitao","year":"2004","unstructured":"Leitao MM Jr et al (2004) Clinicopathologic analysis of early-stage sporadic ovarian carcinoma. Am J Surg Pathol 28(2):147\u2013159","journal-title":"Am J Surg Pathol"},{"key":"1911_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pap.0000213038.85704.e4","volume":"13","author":"Young","year":"2006","unstructured":"Young RH (2006) From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor. Adv Anat Pathol 13(5):205\u2013227","journal-title":"Adv Anat Pathol"},{"key":"1911_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/PAP.0b013e3180504abf","volume":"14","author":"Young","year":"2007","unstructured":"Young RH (2007) From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Adv Anat Pathol 14(3):149\u2013177","journal-title":"Adv Anat Pathol"},{"key":"1911_CR9","unstructured":"Tavassoli FA, Devilee P (2003) Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon"},{"key":"1911_CR10","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/IGC.0b013e3182a01813","volume":"23","author":"Kommoss","year":"2013","unstructured":"Kommoss S et al (2013) Specialized pathology review in patients with ovarian cancer: results from a prospective study. Int J Gynecol Cancer 23(8):1376\u20131382","journal-title":"Int J Gynecol Cancer"},{"key":"1911_CR11","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","volume":"365","author":"Perren","year":"2011","unstructured":"Perren TJ et al (2011) A phase 3 trial of bevacizumab in ovarian cancer. N Engl J Med 365(26):2484\u20132496","journal-title":"N Engl J Med"},{"key":"1911_CR12","doi-asserted-by":"crossref","unstructured":"Soslow R (2011) Common diagnostic discrepancies. In: Soslow RA, Tornos C (Hrsg) Diagnostic pathology of ovarian tumors. Springer, Berlin Heidelberg New York, S\u00a011\u201314","DOI":"10.1007\/978-1-4419-9751-7_2"},{"key":"1911_CR13","unstructured":"Kommoss S, PfistererJ, Diebold J et al (2013) Second opinion pathology in clinical trials of ovarian carcinomas: the use of a new internet-based pathology platform makes rapid case review prior to patient enrolment possible. Poster presentation, 97. Jahrestagung der Deutschen Gesellschaft f\u00fcr Pathologie 2013. Pathologe, Heidelberg, S\u00a06\u2013164"},{"key":"1911_CR14","first-page":"290A","volume":"27","author":"Kommoss","year":"2014","unstructured":"Kommoss S et al (2014) Making Better Use of Resources and Optimizing Quality of Care for Ovarian Cancer Patients Using Internet-Based Second Opinion Pathology \u2013 Standardized in an Ovarian Cancer Network. United States and Canadian Academy of Pathology, 2014 Annual Meeting, San Diego, USA. Modern Pathol 27(Suppl 2):290A","journal-title":"Modern Pathol"},{"key":"1911_CR15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s00292-013-1793-y","volume":"34","author":"Rocken","year":"2013","unstructured":"Rocken C et al (2013) Participation and support of clinical studies and other scientific investigations. Statement of the German Society for Pathology. Pathologe 34(5):466\u2013475","journal-title":"Pathologe"},{"key":"1911_CR16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00292-008-1029-8","volume":"29","author":"Kommoss","year":"2008","unstructured":"Kommoss F, Kommoss S, Schmidt D et al (2008) Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas? Pathologe 29(Suppl 2):157\u2013159","journal-title":"Pathologe"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1911-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-014-1911-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-014-1911-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T06:58:26Z","timestamp":1565593106000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-014-1911-5"}},"subtitle":["Erfahrungen an Kollektiven aus prospektiv randomisierten Phase-III-Studien"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00292-014-1911-5","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}